Need Help? Call 1­-866-­796-­7386
« back to stock screener

  OMCL stock: Omnicell, Inc.

Current Rating
Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$160.58
Market Cap
6.92B
Sector
Health Care
Div. Growth
-
P/E
120.7
P/B
6.51
P/S
6.94
Dividend %
-
P/CF
14.6
P/FCF
32.4
Op. Cash Flow
242.3K
FCF
4.8
Op. Margin
8.00%
Net Margin
6.00%
ROE
6.00%
ROI
2.70%
ROA
3.20%
EPS Growth
18.90%
Current Ratio
3.0
Debt/Equity
48.30%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Cidara Therapeutics Inc (CDTX) $2.13 - - 107.4M Strong Buy
Recro Pharma Inc (REPH) $2.24 - - 114M Strong Buy
AngioDynamics, Inc. (ANGO) $25.31 - - 1.1B Strong Buy
Sensus Healthcare Inc (SRTS) $3.51 - - 60.2M Strong Buy
Rigel Pharmaceuticals, Inc. (RIGL) $3.90 - - 709M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More